ENVERIC BIOSCIENCES INC (ENVB) Stock News

USA - Nasdaq - NASDAQ:ENVB - US29405E4061 - Common Stock

5.94 USD

+0.18 (+3.13%)

Last: 11/25/2025, 8:00:02 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ENVB Latest News, Press Relases and Analysis

All

Press Releases

6 days ago - By: Benzinga - Mentions: BLRX BRTX IBO VNRX ...

12 Health Care Stocks Moving In Wednesday's After-Market Session

11 days ago - By: Enveric Biosciences

Enveric Biosciences Reports Third Quarter 2025 Financial and Corporate Results

a month ago - By: Enveric Biosciences

Enveric Biosciences Announces Reverse Stock Split

a month ago - By: Enveric Biosciences

Enveric Biosciences Further Enhances Intellectual Property Estate with New U.S. Patent Issuance

a month ago - By: Enveric Biosciences

Enveric Biosciences Hires IP Powerhouse to Defend Its U.S. Patent with Claims Relevant to Bretisilocin, Recently Acquired by AbbVie in $1.2 Billion Deal

a month ago - By: Enveric Biosciences

Enveric Biosciences to Explore Digital Asset Treasury Opportunities

2 months ago - By: Enveric Biosciences

Enveric Biosciences Successfully Completes Key Manufacturing Milestones in Support of Planned IND and Clinical Trials

2 months ago - By: Benzinga - Mentions: NBY NEOG PMI APDN ...

12 Health Care Stocks Moving In Monday's After-Market Session

2 months ago - By: Enveric Biosciences, Inc.

Enveric Biosciences Announces Closing of Exercise of Warrants for $2.2 Million Gross Proceeds

2 months ago - By: Enveric Biosciences, Inc.

Enveric Biosciences Announces Exercise of Warrants for $2.2 Million Gross Proceeds

2 months ago - By: Enveric Biosciences

Enveric Biosciences Announces Publication of Two Peer-Reviewed Articles Highlighting Novel Bioproduction Methods for Neuropsychiatric Drug Discovery

2 months ago - By: Enveric Biosciences

Enveric Biosciences Receives FDA Response and Streamlines Plans for EB-003 IND Submission

3 months ago - By: Enveric Biosciences

Enveric Biosciences to Present at H.C. Wainwright 27th Annual Global Investment Conference

3 months ago - By: Enveric Biosciences

Enveric Biosciences Relocates Corporate Headquarters to Cambridge, MA

3 months ago - By: Enveric Biosciences, Inc.

Enveric Biosciences Successfully Completes Pre-IND Dose Range Finding Studies for Lead Candidate EB-003, Targeting Neuropsychiatric Indications

3 months ago - By: Enveric Biosciences

Enveric Biosciences Reports Second Quarter 2025 Financial and Corporate Results

4 months ago - By: Enveric Biosciences

Enveric Biosciences Secures Second U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series

4 months ago - By: Enveric Biosciences

Enveric Biosciences Lead Drug Candidate EB-003 Demonstrates Positive Effects in Preclinical Model of Post-Traumatic Stress Disorder (PTSD)

5 months ago - By: Enveric Biosciences

Enveric Biosciences Announces Data that Broadens Scope of Clinical Indication Potential for Lead Candidate EB-003

5 months ago - By: Enveric Biosciences

Enveric Biosciences Announces Participation in 2025 BIO International Convention

6 months ago - By: Enveric Biosciences

Enveric Biosciences Receives Notice of Allowance for New Class of Low-Hallucinogenic Neuroplastogens Targeting Psychiatric Disorders

6 months ago - By: Enveric Biosciences

Enveric Biosciences Announces Issuance of U.S. Patent Covering a Novel Family of Molecules Including Melatonin Receptor-Targeting Compounds

6 months ago - By: Enveric Biosciences

Enveric Biosciences Reports Positive Preclinical Results for Lead Drug Candidate EB-003

6 months ago - By: Enveric Biosciences

Enveric Biosciences Identifies Neuroplastogen Candidates with Potential to Address Neurodegenerative Disease

7 months ago - By: Enveric Biosciences

Enveric Biosciences Reports First Quarter 2025 Financial and Corporate Results

8 months ago - By: Enveric Biosciences

Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2024

8 months ago - By: Enveric Biosciences, Inc.

Enveric Biosciences Participating in BIO-Europe Spring®

9 months ago - By: Enveric Biosciences

Enveric Biosciences Launches Request-For-Proposals Solicitation Process for PsyAI Trademark